MDI Joint Funding Scheme HRCI & the HRB

November 28th, 2019

MDI Joint Funding Scheme with Health Research Charities Ireland and the Health Research Board

MDI is excited to have recently announced a call for research proposals under the Health Research Charities Ireland and the Health Research Board Joint Funding Scheme. We have encouraged proposals for all types of research, including basic, clinical, psychosocial and health services research. Proposals relating to any of the neuromuscular conditions covered by MDI are eligible to apply. The initial application deadline was in November 2019. The shortlisting process is rigorous, involving MDI’s Research Committee and also international peer review. Once the shortlisting is completed, MDI will then submit up to three proposals to the Health Research Board in early April 2020 for its consideration. If we are successful, the selected project(s) will be funded jointly by MDI and the Health Research Board, beginning November 2020. The award will be for maximum total of €150,000 over three years.

Muscular Dystrophy Ireland is committed to supporting researchers and clinicians to carry out the best quality research into neuromuscular conditions.  We aim to:

  • Gain a greater understanding of neuromuscular conditions in order to develop potential treatments and ensure a route for clinical trials
  • Support more studies into ultra-rare conditions
  • Facilitate quality of life research.

Our research priorities are to:

  • Optimise the potential of genetics in order to enhance our understanding of why people with the same condition are affected differently and, also, so that more people receive a confirmed genetic diagnosis, which will help us to better understand the conditions.
  • Understand disease mechanisms
  • Support treatment development
  • Improve quality of life.

We hope to be announcing good news about our research applications later in the 2020.

To view the original call for research proposals and downloadable resources click here.

Further information is available by contacting Maeve Healy, MDI Information Officer on or on our website

Share Now:

Categories: Uncategorized

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy
  •     •  General
  •     •  MDC1A (merosin-deficient congenital muscular dystrophy)
  •     •  Rigid spine syndrome (RSS)
  •     •  Ullrich congenital muscular dystrophies
  •     •  Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy
  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD)
  •     •  General
  •     •  LGMD 1B (also known as Laminopathy)
  •     •  LGMD 1C (also known as Caveolinopathy)
  •     •  LGMD 2A (also known as Calpainopathy)
  •     •  LGMD 2B (also known as Dysferlinopathy)
  •     •  LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Congenital Fibre-type Disproportion Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositis

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Friedreich’s Ataxia

12. Other (Please Specify)

13. Unspecified